217
Participants
Start Date
August 1, 2017
Primary Completion Date
December 16, 2022
Study Completion Date
December 16, 2022
Hydrus Microstent
Device implanted into the Schlemm's canal of the eye for the purpose of providing a natural outflow pathway for aqueous humor. The Hydrus Microstent is intended for lifetime use of the glaucoma patient.
Ophthalmic surgery
Implantation of the Hydrus Microstent performed under either local or topical ophthalmic anesthesia
Asian Eye Institute, Makati City
Scott & Christie and Associates, Cranberry Township
Center for Sight, Venice
Ocala Eye, Ocala
Hospital Universitario Miguel Servet, Zaragoza
The Eye Centers of Racine and Kenosha, Kenosha
Washington University in St. Louis Ophthalmology, St Louis
Stiles Eyecare, Overland Park
Louisiana Eye and Laser Center, Alexandria
Vold Vision, Fayetteville
Glaucoma Associates of Texas, Dallas
Ophthalmology Associates, Fort Worth
Vale-Asche Russell Clinical Research Center, Houston
R and R Research, LLC, San Antonio
Texan Eye, Austin
El Paso Eye Surgeons, El Paso
Eye Center of Northern Colorado, Fort Collins
Sacramento Eye Consultants, Sacramento
Clínica Oftalmológica, Barranquilla
Manchester Royal Eye Hospital, Manchester
Lead Sponsor
Ivantis, Inc.
INDUSTRY